PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies

Clinical trial NCT05107856 · TERMINATED

Trial details

NCT number: NCT05107856
Sponsor: Prelude Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia B-cell Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Chronic Myelomonocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Myelodysplastic Syndromes Myeloproliferative Neoplasm Small Lymphocytic Lymphoma

Start date: 2022-03-22
Primary completion: 2024-01-19
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.